SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063716
Filing Date
2023-11-14
Accepted
2023-11-14 16:15:35
Documents
82
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qncx-20230930.htm   iXBRL 10-Q 3276958
2 EX-10.2 qncx-ex10_2.htm EX-10.2 124526
3 EX-10.3 qncx-ex10_3.htm EX-10.3 319316
4 EX-10.4 qncx-ex10_4.htm EX-10.4 482893
5 EX-31.1 qncx-ex31_1.htm EX-31.1 15180
6 EX-31.2 qncx-ex31_2.htm EX-31.2 15174
7 EX-32.1 qncx-ex32_1.htm EX-32.1 12253
8 EX-32.2 qncx-ex32_2.htm EX-32.2 12292
9 GRAPHIC img245295508_0.jpg GRAPHIC 18994
10 GRAPHIC img246219029_0.jpg GRAPHIC 15704
  Complete submission text file 0000950170-23-063716.txt   13174602

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qncx-20230930_pre.xml EX-101.PRE 441921
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qncx-20230930_cal.xml EX-101.CAL 56747
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qncx-20230930.xsd EX-101.SCH 63218
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qncx-20230930_def.xml EX-101.DEF 270951
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qncx-20230930_lab.xml EX-101.LAB 551215
76 EXTRACTED XBRL INSTANCE DOCUMENT qncx-20230930_htm.xml XML 2500907
Mailing Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38890 | Film No.: 231406456
SIC: 2836 Biological Products, (No Diagnostic Substances)